Floatz logo

Lactobacillus Rhamnosus Gg

Spinal Cord Injury

Medstar Health Research InstituteUNKNOWNEarly Phase 1Active
C
38/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
81/ 100

Competitive context

18 Active assets in the Spinal Cord Injury cohort.

Asset / SponsorPhaseRating
Pregabalin
Ju Seok Ryu
Phase 4BBB
Gabapentin
MetroHealth Medical Center
Phase 4BB
VENLOR
University of Washington
Phase 4BB
Semaglutide
James J. Peters Veterans Affairs Medical Center
Phase 4BB
Amitriptyline
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase 4BB

View all 42 →

Same molecule, other indications

Lactobacillus Rhamnosus Gg is also rated in:

spina bifidaActive
C
Indicative · Early Phase 1
39 / 100
View asset →
urinary tract infectionActive
C
Indicative · Early Phase 1
39 / 100
View asset →
multiple sclerosisActive
C
Indicative · Early Phase 1
34 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →